Log in

Relevant bibliographies by topics / Pricing of medicines / Books

To see the other types of publications on this topic, follow the link: Pricing of medicines.

Books on the topic 'Pricing of medicines'

Author: Grafiati

Published: 28 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Pricing of medicines.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Martina, Garau, Mestre-Ferrandiz Jorge, and Office of Health Economics (London, England), eds. European medicines pricing and reimbursement: Now and the future. Radcliffe, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lalitha, N. Government intervention and prices of medicines: Lessons from Tamil Nadu. Gujarat Institute of Development Research, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Malanyaon, Olympia P. Q. The pricing of medicines and its impact on the urban poor. Center for Social Policy and Public Affairs, Ateneo de Manila University, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

National Center for Health Services Research and Health Care Technology Assessment (U.S.), ed. Prescribed medicines: A summary of use and expenditures by Medicare beneficiaries. Dept. of Health & Human Services, Public Health Service, National Center for Health Services Research and Health Care Technology Assessment, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Patented Medicine Prices Review Board Canada. The impact of federal regulation of patented drug prices. The Board, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Avorn, Jerry. Powerful medicines: The benefits, risks, and costs of prescription drugs. Knopf, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Babar, Zaheer-ud-din. The reality of medicine prices in Malaysia. Penerbit Universiti Sains Malaysia, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Babar, Zaheer-ud-din. The reality of medicine prices in Malaysia. Penerbit Universiti Sains Malaysia, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Marian, Uhlman, ed. Making medicine, making money. Andrews and McMeel, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Office, General Accounting. Prescription drugs: Companies typically charge more in the United States than in Canada : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives. The Office, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Office, General Accounting. Prescription drugs: Prices available through discount cards and from other sources : [report to] Congressional Requesters. U.S. General Accounting Office, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Office, General Accounting. Prescription drugs: Spending controls in four European countries : report to the Chairman, Special Committee on Aging, U.S. Senate. The Office, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Office, General Accounting. Prescription drugs: Information on selected drug utilization review systems : report to the chairman, Special Committee on Aging, U.S. Senate. The Office, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Office, General Accounting. Prescription drugs: Drug company programs help some people who lack coverage : report to Congressional Requesters. U.S. General Accounting Office, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Office, General Accounting. Prescription drugs: Changes in prices for selected drugs : report to congressional requesters. GAO, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Office, General Accounting. Prescription drugs: Many factors affected FDA's approval of selected "pipeline" drugs : report to congressional requesters. The Office, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Office, General Accounting. Prescription drugs: Expanding access to federal prices could cause other price changes : report to congressional requesters. The Office, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Garrison, Louis P. A descriptive analysis of Medicare hospital episodes with critical care billings: Implications for bundling services for pricing. Project HOPE Center for Health Affairs, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Office, General Accounting. Prescription drug prices: Analysis of Canada's Patented Medicine Prices Review Board : report to the chairman, Special Committee on Aging, U.S. Senate. The Office, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee. State Medicaid drug formularies: Cost saving measure or second-class medicine? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, June 9, 1993. U.S. G.P.O., 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee. State Medicaid drug formularies: Cost saving measure or second-class medicine? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, June 9, 1993. U.S. G.P.O., 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Office, General Accounting. Prescription drug prices: Official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate. The Office, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Garau, Martina, Jorge Mestre-Ferrandiz, and Michael Loh. European Medicines Pricing and Reimbursement. Edited by Garau Martina and Mestre-Ferrandiz Jorge. CRC Press, 2018. http://dx.doi.org/10.1201/9781315383064.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

(Editor), Martina Garau, and Jorge Mestre-Ferrandiz (Editor), eds. European Medicines Pricing and Reimbursement. Radcliffe Publishing Ltd, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Loh, Michael, Martina Garau, and Jorge Mestre-Ferrandiz. European Medicines Pricing and Reimbursement: Now and the Future. Taylor & Francis Group, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Loh, Michael, Martina Garau, and Jorge Mestre-Ferrandiz. European Medicines Pricing and Reimbursement: Now and the Future. Taylor & Francis Group, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Loh, Michael, Martina Garau, and Jorge Mestre-Ferrandiz. European Medicines Pricing and Reimbursement: Now and the Future. Taylor & Francis Group, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Loh, Michael, Martina Garau, and Jorge Mestre-Ferrandiz. European Medicines Pricing and Reimbursement: Now and the Future. Taylor & Francis Group, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Pérez-Casas, Carmen. HIV/AIDS medicines pricing report: Setting objectives: is there a political will? Medicins San Frontieres, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Availability and Pricing of Essential Medicines in Myanmar: Influencing Factors and Recent Trends. Washington, DC: World Bank, 2024. http://dx.doi.org/10.1596/41389.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Smith, Brian D. New Drugs, Fair Prices: Managing the Pharmaceutical Innovation Ecosystem for Sustainable and Affordable New Medicines. Routledge, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Smith, Brian D. New Drugs, Fair Prices: Managing the Pharmaceutical Innovation Ecosystem for Sustainable and Affordable New Medicines. Taylor & Francis Group, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Smith, Brian D. New Drugs, Fair Prices: Managing the Pharmaceutical Innovation Ecosystem for Sustainable and Affordable New Medicines. Taylor & Francis Group, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Smith, Brian D. New Drugs, Fair Prices: Managing the Pharmaceutical Innovation Ecosystem for Sustainable and Affordable New Medicines. Routledge, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

New Drugs, Fair Prices: Managing the Pharmaceutical Innovation Ecosystem for Sustainable and Affordable New Medicines. Taylor & Francis Group, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Differential pricing of pharmaceuticals inside Europe: Exploring compulsory licenses and exhaustion for access to patented essential medicines. Nomos, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Avorn, Jerry. Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. Knopf, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Avorn, Jerry. Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. Vintage, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Voit, Wolfgang, ed. Werberecht und Absatzförderung/Preisrecht. Nomos Verlagsgesellschaft mbH & Co. KG, 2019. http://dx.doi.org/10.5771/9783748903499.

Full text

Abstract:

The first lecture given at the 21st Marburg debates on pharmaceutical law addressed the criminal consequences of advertising law going hand in hand with sales promotion. It focused on clarifying which forms of cooperation are still desirable, necessary and allowed. In addition to dealing with the regulatory requirements involved in the contractual organisation of digital communication channels and the legal options offered by the information conveyed, among others, by health insurance companies about the economic feasibility of regu-lations on medication, the conference also highlighted the op

APA, Harvard, Vancouver, ISO, and other styles

40

McCann, Henry, and Heiner Fruehauf. Pricking the Vessels: Bloodletting Therapy in Chinese Medicine. Kingsley Publishers, Jessica, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

McCann, Henry, and Heiner Fruehauf. Pricking the Vessels: Bloodletting Therapy in Chinese Medicine. Kingsley Publishers, Jessica, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Welsh, Robert. 1996 Fee and Coding Standard: National Pricing Guide for Setting Fees. Medicode Inc, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Practicing Medicine Profitably : A Critical Relationship of Cost Analysis to Pricing Strategies in a Changing Medical Enviroment. Amer College Physician Executives, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Prescription drugs: Selected direct-to-consumer advertising studies have methodological flaws : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives. The Office, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

South Florida's access to affordable prescription drugs: Costs and benefits of alternative solutions : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, March 10, 2003. U.S. G.P.O., 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

US GOVERNMENT. The Economic Aspects of the Pharmaceutical Industry in the United States: Hearing Before the Subcommittee on Human Rights and Wellness of the Committe. Government Printing Office, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Examining prescription drug importation: A review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002. U.S. G.P.O., 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

US GOVERNMENT. Reimbursement and access to prescription drugs under Medicare part B: Hearing before the Subcommittee on Health Care of the Committee on Finance, United ... second session, March 14, 2002 (S. hrg). For sale by the Supt. of Docs., U.S. G.P.O., [Congressional Sales Office], 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Greider, Katharine. Big Fix: How the Pharmaceutical Industry Rips off American Consumers. PublicAffairs, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Prescription for the people: An activist's guide to making medicine affordable for all. ILR Press, an imprint of Cornell University Press, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!